Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...
A late-breaking clinical trial has shown that muvalaplin, an innovative oral medication, can safely and effectively lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback